tm
Seeing Is Believing
tm
Seeing Is Believing
SYRS is currently covered by 5 analysts
Syros Pharmaceuticals's activity chart (see below) currently has 36 price targets and 54 ratings on display. The stock rating distribution of SYRS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 39.15% with an average time for these price targets to be met of 267.13 days.
Highest price target for SYRS is $7, Lowest price target is $2.
Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 01-Nov-2024. First documented stock forecast 18-Jul-2016.
Currently out of the existing stock ratings of SYRS, 20 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$6
$3.39 (129.89%)
$6
1 years 11 months 16 days ago
(01-Nov-2024)
2/12 (16.67%)
$3.73 (164.32%)
30
Buy
$5
$2.39 (91.57%)
$7
2 years 2 months 4 days ago
(13-Aug-2024)
2/11 (18.18%)
$3.08 (160.42%)
82
Buy
$4
$1.39 (53.26%)
$15
2 years 2 months 4 days ago
(13-Aug-2024)
1/5 (20%)
$2.08 (108.33%)
1063
Buy
$13
$5.4 (71.05%)
$15
3 years 7 months 13 days ago
(03-Mar-2023)
1/4 (25%)
$9.07 (230.79%)
155
Buy
$19
$14.86 (358.94%)
$23
4 years 4 months 8 days ago
(08-Jun-2022)
1/3 (33.33%)
$2.24 (59.78%)
17
What is SYRS (Syros Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on SYRS (Syros Pharmaceuticals)?
Which analyst has the current lower performing score on SYRS (Syros Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on SYRS (Syros Pharmaceuticals)?
Which analyst is the currently most bullish on SYRS (Syros Pharmaceuticals)?
Which analyst is the currently most reserved on SYRS (Syros Pharmaceuticals)?
